Skip to content

Patient Experience and Bowel Preparation for Transvaginal Surgical Management of Vaginal Prolapse

Patient Experience and Bowel Preparation for Transvaginal Surgical Management of Vaginal Prolapse

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01431040
Enrollment
150
Registered
2011-09-09
Start date
2011-01-31
Completion date
2013-08-31
Last updated
2014-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preoperative Bowel Regimen, Value of the Bowel Preparation and Diet Change Versus no Intervention

Keywords

Bowel Prep, No bowel prep, Vaginal reconstructive or obliterative surgery

Brief summary

Preoperative bowel preparation for surgical management of pelvic floor disorders is performed inconsistently, and includes no prep, the use of dietary changes or bowel altering interventions. Retrospective studies of emergency colonic surgery first demonstrated a low rate of infectious complications without a bowel prep. Recently, data supporting the routine use of mechanical cleansing for elective colorectal surgery has demonstrated the surgical outcomes are similar between patients that undergo a bowel preparation versus those that do not, indicating that the long held dogma of mechanical bowel preparation should be used selectively. Despite routine use, there is a paucity of literature addressing the approach to, and/or need for preoperative bowel management at the time of vaginal reconstructive or obliterative surgery. The majority of the pelvic floor disorder population is older, tending to have more bowel dysfunction (especially symptoms of constipation) than younger women. The aim of this study is to evaluate preoperative bowel management strategy as it relates to the total care of the vaginal surgery patients' intra-and post-operative bowel function and overall patient experience. Two commonly used pre-operative bowel prep strategies: no preoperative bowel prep versus clear fluids and 2-enema prep. The aim is to assess the value of bowel preparation or diet change in vaginal surgery, both from the physician's and patient's point of view. In this pilot study, subjects are randomized to either a clear liquid diet the day prior to surgery with 2 enemas and nothing by mouth (NPO) after midnight, or NPO after midnight without any dietary changes or enemas. Our aims are: \*Primary - To assess the surgeons' objective intraoperative evaluation of the effects of bowel preparation (adequate visualization, stooling during case, difficulty with bowel handling) \*Secondary - (1)To characterize the patients' experience and acceptance of preoperative bowel management regimen versus no preoperative bowel preparation(2) To characterize the patients' postoperative experience and determine if the preoperative bowel regimen affects time to first bowel movement/first normal stool as well as stool experience as recorded by bowel diary (3)Evaluate the incidence of complications between the two groups (4)Characterize other descriptive qualities of the patients' operative experience(duration of case, length of hospital stay)

Interventions

Participants in this group will have a regular diet and no bowel prep the day prior surgery up until midnight.

OTHERClear liquid diet and 2 Fleet's enemas

Participants in this group will receive a clear liquid diet and 2 Fleets enemas in the late afternoon prior to surgery.

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
19 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 19 * Female * Undergoing transvaginal reconstructive surgical intervention for vaginal prolapse (apical suspension and posterior compartment repair required, other concurrent surgery allowed)

Exclusion criteria

* Male * Pregnant, planning pregnancy, or less than 1 year from delivery * History of total colectomy or prior ileostomy * Inflammatory bowel disorder (Crohn's disease and ulcerative colitis) formally diagnosed * Inability to understand written study material (including non-English speaking) * Inability to give consent * Presently diagnosed colorectal cancer * Undergoing chemotherapy and/or radiation * Chronic constipation suggestive of colonic inertia defined as fewer that 3 stools per week (Rome III guidelines) * Severe neurological diseases (such as Multiple Sclerosis)

Design outcomes

Primary

MeasureTime frameDescription
Surgeon assessment of bowel preparationWill be evaluated at 1 yearThe primary outcome measure will be measured using the surgeon satisfaction questionnaire which is filled out immediately post-op. The surgeon assessment of the bowel preparation and its potential outcome on the surgical field (adequate visualization, stooling during case, and difficulty with bowel handling) will be measured.

Secondary

MeasureTime frameDescription
Participant experience and acceptance of preoperative bowel management verses no preoperative bowel preparationWill be evaluated at 1 yearParticipants will complete a patient assessment/satisfaction questionnaire.
Bowel Diary and Bristol Stool ScaleWill be evaluated at 1 yearParticipants will receive 3 seven day bowel diaries,completing one week prior to surgery, and 2 weeks post-operatively. The Bristol Stool Scale is also included as part of the diary and participants are to record each bowel movement during the 3 week period. The information is returned to the physician at the post-operative visit, which occurs approximately 6 weeks after surgery.
Complications between the two groupsWill be evaluated at 1 yearAny complications that arise will be assessed as they occur and the incidence of complications, if any between the two groups, including wound infection (as defined by erythema, purulent material that was treated with antibiotics, re-operation, or drainage), surgical site breakdown, bowel injury or other unintended injury of adjacent anatomy will be assessed after all the procedures are completed.
Duration of the CaseWill be evaluated at 1 yearThis relates to the overall operative procedure recorded in total operative time.
Length of hospital stayWill be evaluated at 1 yearThe length of stays will be assessed to gather the average time of stay.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026